Azenta Inc (AZTA)
53.42
+0.85
(+1.62%)
USD |
NASDAQ |
May 03, 16:00
53.38
-0.04
(-0.07%)
After-Hours: 20:00
Azenta Cash and Short Term Investments (Quarterly): 984.14M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 984.14M |
September 30, 2023 | 1.018B |
June 30, 2023 | 1.124B |
March 31, 2023 | 1.181B |
December 31, 2022 | 1.131B |
September 30, 2022 | 1.570B |
June 30, 2022 | 2.183B |
March 31, 2022 | 2.753B |
December 31, 2021 | 215.22M |
September 30, 2021 | 227.51M |
June 30, 2021 | 269.96M |
March 31, 2021 | 320.21M |
December 31, 2020 | 308.57M |
September 30, 2020 | 250.70M |
June 30, 2020 | 256.77M |
March 31, 2020 | 242.44M |
December 31, 2019 | 346.55M |
September 30, 2019 | 335.77M |
June 30, 2019 | 156.89M |
March 31, 2019 | 137.26M |
December 31, 2018 | 135.82M |
September 30, 2018 | 243.99M |
June 30, 2018 | 221.47M |
March 31, 2018 | 234.67M |
December 31, 2017 | 218.00M |
Date | Value |
---|---|
September 30, 2017 | 101.65M |
June 30, 2017 | 117.09M |
March 31, 2017 | 105.43M |
December 31, 2016 | 83.81M |
September 30, 2016 | 85.12M |
June 30, 2016 | 66.13M |
March 31, 2016 | 62.23M |
December 31, 2015 | 55.61M |
September 30, 2015 | 150.74M |
June 30, 2015 | 141.22M |
March 31, 2015 | 142.50M |
December 31, 2014 | 136.41M |
September 30, 2014 | 162.24M |
June 30, 2014 | 172.62M |
March 31, 2014 | 135.56M |
December 31, 2013 | 123.44M |
September 30, 2013 | 128.87M |
June 30, 2013 | 103.09M |
March 31, 2013 | 106.36M |
December 31, 2012 | 102.99M |
September 30, 2012 | 140.28M |
June 30, 2012 | 149.17M |
March 31, 2012 | 152.21M |
December 31, 2011 | 128.68M |
September 30, 2011 | 124.53M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
156.89M
Minimum
Jun 2019
2.753B
Maximum
Mar 2022
782.88M
Average
335.77M
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
Bruker Corp | 340.10M |
Harvard Bioscience Inc | 4.283M |
Bionano Genomics Inc | 101.89M |
Akoya Biosciences Inc | 83.12M |
Singular Genomics Systems Inc | 173.94M |